|
|
Volumn 111, Issue 7, 2014, Pages 1319-1326
|
|
Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAMPTOTHECIN;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE INHIBITOR;
INDOLE DERIVATIVE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PARP1 PROTEIN, HUMAN;
RUCAPARIB;
TOP1 PROTEIN, HUMAN;
ARTICLE;
CELL SURVIVAL;
DNA REPAIR;
DOUBLE STRANDED DNA BREAK;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SCREENING;
HUMAN;
K562 CELL LINE;
METABOLISM;
S PHASE CELL CYCLE CHECKPOINT;
CAMPTOTHECIN;
CELL SURVIVAL;
DNA BREAKS, DOUBLE-STRANDED;
DNA REPAIR;
DNA TOPOISOMERASES, TYPE I;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
HUMANS;
INDOLES;
K562 CELLS;
POLY(ADP-RIBOSE) POLYMERASES;
S PHASE CELL CYCLE CHECKPOINTS;
TOPOISOMERASE I INHIBITORS;
|
|
EID: 84909995009
PISSN: None
EISSN: 15321827
Source Type: Journal
DOI: 10.1038/bjc.2014.378 Document Type: Article |
|
Times cited : (38)
|
|
References (0)
|
